Skip to main content
. 2015 Jun 10;6(27):24205–24217. doi: 10.18632/oncotarget.4434

Figure 4. Changes of BRAF, NRAS and KRAS mutational burden during disease progression.

Figure 4

Allele frequencies of each variant are plotted at both time points for patients found mutated at diagnosis and/or relapse. The VAFs of mutations co-occurring in an individual patient are identified by the same color.

HHS Vulnerability Disclosure